Press release
Vascular Stents Market is Expected to Reach US$ 17.1 Billion by 2032- IMARC Group
๐ ๐๐๐ญ๐จ๐ซ๐ฌ ๐๐๐๐๐๐ญ๐ข๐ง๐ ๐ญ๐ก๐ ๐๐ซ๐จ๐ฐ๐ญ๐ก ๐จ๐ ๐๐๐ฌ๐๐ฎ๐ฅ๐๐ซ ๐๐ญ๐๐ง๐ญ๐ฌ ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ:
๐๐ง๐๐ซ๐๐๐ฌ๐ข๐ง๐ ๐๐ง๐๐ข๐๐๐ง๐๐ ๐จ๐ ๐๐๐ซ๐๐ข๐จ๐ฏ๐๐ฌ๐๐ฎ๐ฅ๐๐ซ ๐๐ข๐ฌ๐๐๐ฌ๐๐ฌ:
The primary driver behind the growth of the vascular stents market is the rising incidence of cardiovascular diseases (CVDs) worldwide. CVDs, which include conditions such as coronary artery disease and peripheral artery disease, continue to be a leading cause of morbidity and mortality globally. The aging population, sedentary lifestyles, and dietary habits contribute to the higher prevalence of CVDs. With a growing number of patients diagnosed with cardiovascular conditions, there is an increased demand for interventional cardiology procedures, including the placement of vascular stents. These stents help to open narrowed or blocked arteries, restoring blood flow and reducing the risk of complications. As a result, the vascular stent market is witnessing significant expansion to meet the escalating healthcare needs of the aging population and those at risk of CVDs.
๐๐๐ฏ๐๐ง๐๐๐ฆ๐๐ง๐ญ๐ฌ ๐ข๐ง ๐๐ญ๐๐ง๐ญ ๐๐๐๐ก๐ง๐จ๐ฅ๐จ๐ ๐ฒ:
Advancements in stent technology have revolutionized the vascular stents market. Manufacturers have been consistently innovating to improve the safety and efficacy of stents, leading to the development of drug-eluting stents (DES) and bioresorbable stents. DES, for instance, are coated with medications that help prevent restenosis, a common problem in which arteries narrow again after stent placement. Furthermore, bioresorbable stents are designed to gradually dissolve in the body, eliminating the need for a permanent implant. These innovations have enhanced patient outcomes, reduced complications, and led to shorter recovery times, making stent implantation a more attractive option for both patients and healthcare providers.
๐๐ซ๐จ๐ฐ๐ข๐ง๐ ๐๐ ๐ข๐ง๐ ๐๐จ๐ฉ๐ฎ๐ฅ๐๐ญ๐ข๐จ๐ง:
The global demographic shift toward an aging population is another significant factor driving the vascular stents market. As individuals age, they are more prone to developing various cardiovascular conditions due to factors such as arterial aging and plaque buildup. This demographic trend has resulted in a higher demand for cardiovascular interventions, including the placement of vascular stents. Moreover, older adults often have multiple comorbidities, making them candidates for complex coronary and peripheral artery procedures, where stents play a crucial role in restoring and maintaining blood flow. The aging population increases the number of potential patients and also drives research and development efforts to create stents tailored to the specific needs of elderly individuals, further fueling market growth.
๐๐จ๐ฆ๐ฉ๐๐ญ๐ข๐ญ๐ข๐ฏ๐ ๐๐๐ง๐๐ฌ๐๐๐ฉ๐ ๐ฐ๐ข๐ญ๐ก ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ:
Medtronic Plc
Abbott Laboratories
Boston Scientific Corporation
Biotronik Se & Co. Kg
Braun Melsungen Ag
Terumo Corporation
Microport Scientific Corporation
Meril Life Sciences Pvt. Ltd.
Vascular Concepts Limited
C.R. Bard Inc.
W.L. Gore and Associates Inc.
Endologix, Inc.
Lombard Medical
Translumina Gmbh
Jotec Gmbh
๐ ๐จ๐ซ ๐๐ง ๐ข๐ง-๐๐๐ฉ๐ญ๐ก ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ, ๐ฒ๐จ๐ฎ ๐๐๐ง ๐ซ๐๐๐๐ซ ๐ฌ๐๐ฆ๐ฉ๐ฅ๐ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐ญ๐ก๐ ๐ซ๐๐ฉ๐จ๐ซ๐ญ:ย https://www.imarcgroup.com/vascular-stents-market/requestsample
Report Segmentation:
The report has segmented the market into the following categories:
๐๐ซ๐๐๐ค๐ฎ๐ฉ ๐๐ฒ ๐๐ซ๐จ๐๐ฎ๐๐ญ ๐๐ฒ๐ฉ๐:
Coronary Stentsย
Peripheral Vascular Stents
Evar Stent Grafts
Coronary stents dominate the market due to the high prevalence of coronary artery disease and the widespread adoption of coronary stents as a standard intervention for restoring blood flow in coronary arteries, making it the dominant category in the stent market.
๐๐ซ๐๐๐ค๐ฎ๐ฉ ๐๐ฒ ๐๐๐ญ๐๐ซ๐ข๐๐ฅ:
Metallic Stents
Cobalt Chromium
Platinum Chromium
Nickel Titanium
Stainless Steel
Others
Metallic stents hold maximum number of shares due to their proven durability, flexibility, and effectiveness in maintaining vessel patency, making them the preferred choice for a wide range of cardiovascular interventions.
๐๐ซ๐๐๐ค๐ฎ๐ฉ ๐๐ฒ ๐๐จ๐๐ ๐จ๐ ๐๐๐ฅ๐ข๐ฏ๐๐ซ๐ฒ:
ย Balloon-Expandable Stents
ย Self-Expanding Stents
Balloon-expandable stents represent the largest segment due to their precise and controlled deployment, which allows for effective treatment of narrowed or blocked arteries, making them a preferred choice for interventional procedures.
๐๐ซ๐๐๐ค๐ฎ๐ฉ ๐๐ฒ ๐๐ง๐-๐๐ฌ๐๐ซ:
Hospitals and Cardiac Centers
Ambulatory Surgical Centers
Hospitals and cardiac centers dominate the market due to their central role in providing comprehensive cardiovascular care, including diagnosis, treatment, and surgical interventions, making them primary users of vascular stents.
๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐๐๐ค๐ฎ๐ฉ ๐๐ฒ ๐๐๐ ๐ข๐จ๐ง:
North America (United States, Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa
North America's dominance in the vascular stents market is attributed to its robust healthcare infrastructure, high prevalence of cardiovascular diseases, and substantial investments in medical research and innovation.
๐๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ ๐ ๐ฎ๐ฅ๐ฅ ๐๐๐ฉ๐จ๐ซ๐ญ ๐ฐ๐ข๐ญ๐ก ๐๐๐๐ฅ๐ ๐จ๐ ๐๐จ๐ง๐ญ๐๐ง๐ญ๐ฌ:ย https://www.imarcgroup.com/vascular-stents-market
๐๐ฅ๐จ๐๐๐ฅ ๐๐๐ฌ๐๐ฎ๐ฅ๐๐ซ ๐๐ญ๐๐ง๐ญ๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐๐ง๐๐ฌ:
The vascular stents market is dynamic, with companies continually developing and launching new stent products. Regulatory approvals for these innovations are crucial in driving market growth. As new stents with improved features and efficacy gain regulatory clearance, they enter the market, offering more options to healthcare providers and patients. Additionally, technological advancements in imaging techniques, such as angiography and intravascular ultrasound (IVUS), are playing a significant role in the vascular stents market. These advanced imaging tools allow healthcare professionals to precisely diagnose and assess vascular conditions, helping them select the most appropriate stent type and placement strategy. This results in improved patient outcomes and drives the demand for vascular stents.
๐๐ซ๐จ๐ฐ๐ฌ๐ ๐๐จ๐ซ๐ ๐๐๐ญ๐๐ฌ๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ:
https://www.imarcgroup.com/detox-drinks-market
https://www.imarcgroup.com/delivery-drones-market
https://www.imarcgroup.com/alopecia-treatment-market
https://www.imarcgroup.com/pet-accessories-market
https://www.imarcgroup.com/wires-cables-market
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Vascular Stents Market is Expected to Reach US$ 17.1 Billion by 2032- IMARC Group here
News-ID: 3361665 • Views: โฆ
More Releases from IMARC Group
Global Cellulose Prices Q2 2025 - Trend, News & Insights
North America Cellulose Prices Movement Q2
Cellulose Prices in United States:
In Q2 2025, US Cellulose Prices were pressured by reduced output at pulp mills due to maintenance and labor shortages. Timber harvesting delays from adverse weather constrained raw material supply. Steady demand from packaging and construction supported consumption, while rising fuel surcharges and logistics costs added to overall pricing challenges.
Get the Real-Time Prices Analysis: https://www.imarcgroup.com/cellulose-pricing-report/requestsample
APAC Cellulose Prices Movement Q2:
Cellulose Prices inโฆ
E-Waste Manufacturing Plant Report 2025: Raw Materials Requirement, Setup Cost a โฆ
E-Waste refers to discarded electronic devices such as computers, smartphones, televisions, and household appliances that have reached the end of their life cycle. It contains both valuable materials like gold, copper, and rare earth elements, as well as hazardous substances such as lead, mercury, and cadmium, making proper recycling crucial for environmental safety and resource recovery.
Setting up an e-waste recycling plant requires investment in land, machinery for dismantling and extraction,โฆ
Cement Bricks Manufacturing Plant Report 2025: Business Plan, and Setup Details
Cement bricks are solid or hollow rectangular blocks made from a mixture of cement, sand, and aggregates, molded and cured for strength and durability. They are widely used in construction due to their uniform shape, load-bearing capacity, resistance to fire and weather, and cost-effectiveness compared to traditional clay bricks.
Setting up a cement bricks manufacturing plant involves securing land, installing machinery like mixers and molding units, sourcing raw materials, and employingโฆ
Propyl Cyanoacetate Production Cost Report 2025: Detailed Guide on Plant Setup, โฆ
Setting up a propyl cyanoacetate production facility necessitates a detailed market analysis alongside granular insights into various operational aspects, including unit processes, raw material procurement, utility provisions, infrastructure setup, machinery and technology specifications, workforce planning, logistics, and financial considerations.
IMARC Group's report titled "Propyl Cyanoacetate Production Cost Analysis Report 2025: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" offers a comprehensive guide for establishing a propyl cyanoacetateโฆ
More Releases for Stent
Airway Stent Lung Stent Market Size 2024 to 2031.
Market Overview and Report Coverage
An airway stent, also known as a lung stent, is a medical device used to open up blocked airways in the lungs. It is typically used in patients with conditions such as tracheal or bronchial stenosis, tumors, or strictures. The global airway stent lung stent market is expected to grow at a CAGR of 6.10% during the forecasted period.
The future outlook for the airway stent lungโฆ
Airway Stent and Lung Stent Market Revenue Surges: Acumen Research Projection
The airway stent/lung stent market is witnessing a significant surge in revenue, projected to increase by USD 204.4 million by 2032. This growth is driven by a Compound Annual Growth Rate (CAGR) of 6.3% from 2023 to 2032. This article delves into the various facets of the market, including regional dominance, segment growth, and the underlying factors fueling this expansion.
Market Revenue Growth
The global airway stent/lung stent market is on anโฆ
Gel Stent Market Will Generate Booming Growth Opportunities to 2032 | Clinical P โฆ
The latestย Globalย Gel Stentย Marketย research report 2022 provides detailed information about the market overview, prevalent trends, demand, and recent developments impacting the market growth during the upcoming years. Theย Gel Stentย market report also covers the size, share, potential growth, and industry strategy followed by prominent players. This report also includes profiles for major companies within the market.ย There is wide acceptance of Gel Stent across the buyers' segments and this has been driving theโฆ
Gel Stent Market To Offer Lucrative Growth Opportunities to 2032 | Clinical Phas โฆ
The global Gel Stent market research report offers domain wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. The wide application portfolio of Gel Stent is one of factors driving the growth of domain worldwide. The global market is moderately competitive with a blend of global and regional players. The industry players invest significantly in R&D to enhance their offerings. The entireโฆ
Global Evar Stent Grafts Market, Global Evar Stent Grafts Industry, Covid-19 Imp โฆ
The aortic-aneurysm is a swelling & dilation the wall of blood-vessel, in general an artery, owing to weakness or degeneration, which develops in the segment of artery wall. Endovascular-aneurysm-repair or EVAR contains the conveying of implant in the aneurysm through small-groin incisions with X-rays to guide the graft into place. EVAR is an ideal treatment option for the aortic aneurysm considering to its advantages over the open surgery. Some ofโฆ
Airway Stent/Lung Stent Market Size, Share, Trends & Forecast 2019-2025
The airway stent/lung stent market is forecast to grow at a CAGR of 5.8% attributed to the increasing adoption of bronchial stents in the treatment of lung cancer and other chronic respiratory diseases. The airway invasion is common in the patient diagnosed with lung cancer. These patients may develop stridor, intractable cough, post obstructive, dyspnea, hemorrhage, pneumonia and intractable cough due to tracheobronchial tumor extension. The optimal management of patientsโฆ
